1-3 of 3
Charles Michael Farber, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of an Ongoing Phase 2 Study of Brentuximab Vedotin with Rchp As Frontline Therapy in Patients with High-Intermediate/High-Risk Diffuse Large B Cell Lymphoma (DLBCL)

Lihua E. Budde, MD PhD, Ahmad Halwani, Christopher A. Yasenchak, Charles Michael Farber, MD PhD, John M Burke, MD, Luis E. Fayad, MD, Beata Holkova, MD, Mark Knapp, MD, Kathryn S. Kolibaba, MD, Ranjana H Advani, MD, Stephen M Ansell, MD, PhD, Dipti Patel-Donnelly, MD, Habte A. Yimer, MD, Scott E. Smith, MD PhD, Moshe Yair Levy, MD, Mahesh Seetharam, MD, David Belada, MD PhD, Donald Brooks, MD, Edwin C. Kingsley, MD, Leonard M. Klein, Nina Wagner-Johnston, MD, Katherine Ruffner, Nancy L Bartlett, MD
Journal: Blood
Blood (2016) 128 (22): 104.
https://doi.org/10.1182/blood.V128.22.104.104
Published: 2016
Journal Articles

Characteristics of Patients (Pts) with Chronic Lymphocytic Leukemia (CLL) Receiving Rituximab Monotherapy in the Connect ® CLL Registry

Jeff Sharman, MD, Matthew Davids, MD, Charles Michael Farber, MD PhD, David L. Grinblatt, MD, Neil E. Kay, MD, Nicole Lamanna, MD, Anthony R. Mato, MD, Chadi Nabhan, MD MBA, FACP, Kristen Sullivan, MBA, CCRA, E. Dawn Flick, RPh, MPH, ScD, Pavel Kiselev, PhD, Shriya Bhushan, PharmD, Arlene S. Swern, PhD, Christopher R. Flowers, MD
Journal: Blood
Blood (2016) 128 (22): 5941.
https://doi.org/10.1182/blood.V128.22.5941.5941
Published: 2016
Journal Articles

Early Progression of Disease (< 2 Years) Is a Negative Predictor of Survival in Patients (Pts) with Chronic Lymphocytic Leukemia (CLL): An Analysis from the Connect ® CLL Registry

Inhye E Ahn, MD, Charles Michael Farber, MD PhD, Matthew Davids, MD, David L. Grinblatt, MD, Nicole Lamanna, MD, Anthony R. Mato, MDMSCE, Chadi Nabhan, MD MBA, FACP, Pavel Kiselev, PhD, Arlene S. Swern, PhD, E. Dawn Flick, RPh, MPH, ScD, Shriya Bhushan, PharmD, Kristen Sullivan, MBA, CCRA, Jeff Sharman, MD, Christopher R. Flowers, MD
Journal: Blood
Blood (2016) 128 (22): 3581.
https://doi.org/10.1182/blood.V128.22.3581.3581
Published: 2016